Detalhe da pesquisa
1.
Evaluation of the effect of sofosbuvir and daclatasvir in hospitalized COVID-19 patients: a randomized double-blind clinical trial (DISCOVER).
J Antimicrob Chemother
; 77(3): 758-766, 2022 02 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-34849957